SIR is a buy but chart says top of range in uptrend and the SP should fall in the near term. Buy on weakness in a couple of days.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025